Halozyme Reports First Quarter 2022 Results

Go back to Halozyme Reports First Quarter 2022 Results
Halozyme Therapeutics, Inc. (NASDAQ: HALO) Delayed: 76.57 -1.7 (2.17%)
Previous Close $78.27    52 Week High $18.39 
Open $78.47    52 Week Low $6.96 
Day High $78.50    P/E N/A 
Day Low $76.26    EPS $-0.58 
Volume 283,930